PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO), a Company dedicated to orphan oncology products and specialty products, announces that its Shareholders’ meeting was held today at its headquarters and has adopted all the resolutions supported by its Board of Directors.
